Cash Flow Mirum Pharmaceuticals, Inc. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
No of Months
12
12
12
12
12
12
Profit Before Tax
-86.00
-162.00
-142.00
-83.00
-103.00
-52.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
22.00
-22.00
-21.00
16.00
0.00
7.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
10.00
-70.00
-120.00
-132.00
-89.00
-39.00
Cash Flow from Investing Activities
-90.00
-107.00
7.00
48.00
37.00
-127.00
Cash Flow from Financing Activities
17.00
336.00
109.00
73.00
181.00
127.00
Net Cash Inflow / Outflow
-63.00
158.00
-3.00
-10.00
130.00
-39.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
-1.00
0.00
0.00
0.00
0.00
0.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in USD Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Mirum Pharmaceuticals, Inc.
Figures in Million
consolidated Cash Flow Results
Change(USD)
Change(%)
Profit Before Tax
-86.912
-400.666
314.00
78.31%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
22.591
84.762
-62.00
-73.35%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
10.325
-267.194
277.00
103.86%
Cash Flow from Investing Activities
-90.125
266.678
-356.00
-133.80%
Cash Flow from Financing Activities
17.699
10.663
7.00
65.99%
Net Cash Inflow / Outflow
-63.398
10.147
-73.00
-724.80%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
-1.297
0
-1.00
0.00%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'24
YoY Growth in year ended Dec 2024 is 114.55% vs 40.95% in Dec 2023
Dec'24
Dec'23
Change(%)
Cash Flow from Operating Activities
10.32
-70.94
114.55%
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
